Combination of imatinib with rapamycin or RAD001 acts synergistically only in Bcr-Abl-positive cells with moderate resistance to imatinib.
- Resource Type
- Letter
- Authors
- Dengler, J.; von Bubnoff, N.; Decker, T.; Peschel, C.; Duyster, J.
- Source
- Leukemia (08876924). Oct2005, Vol. 19 Issue 10, p1835-1838. 4p. 4 Graphs.
- Subject
- *LETTERS to the editor
*ANTINEOPLASTIC agents
- Language
- ISSN
- 0887-6924
Presents a letter to the editor in response to the article "Combination of Imatinib With Rapamycin or RAD001 Acts Synergistically Only in Bcr-Abl-Positive Cells With Moderate Resistance to Imatinib," previously published in the journal "Leukemia."